Literature DB >> 9363434

Acceptor specificity of GDP-Fuc:Gal beta 1-->4GlcNAc-R alpha 3-fucosyltransferase VI (FucT VI) expressed in insect cells as soluble, secreted enzyme.

T De Vries1, M P Palcic, P S Schoenmakers, D H Van Den Eijnden, D H Joziasse.   

Abstract

As an extension of previous study (de Vries et al., 1995, J. Biol. Chem., 270, 8712-8722) the acceptor specificity of recombinant FucT VI, expressed in insect cells as soluble enzyme, and purified from the growth medium by affinity chromatography, was analyzed toward a broad panel of oligosaccharide and glycoprotein substrates. It was found that FucT VI effectively utilizes any type-2-chain based structure (Gal beta 1-->4GlcNAc-R). Neutral as well as sialylated structures are fucosylated with high efficiency. To identify polar groups on acceptors that function in enzyme binding, deoxygenated substrate analogs were tested as acceptors. FucT VI had an absolute requirement for a hydroxyl at C-6 of galactose in addition to the accepting hydroxyl at C-3. Thus, FucT VI, although different from FucT III, IV, and V in acceptor properties, seems to bind the acceptor in a similar way.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9363434     DOI: 10.1093/glycob/7.7.921

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  10 in total

1.  Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function.

Authors:  D C Poland; C G Schalkwijk; C D Stehouwer; C A Koeleman; B van het Hof; W van Dijk
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

Review 2.  Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells.

Authors:  E Grabenhorst; P Schlenke; S Pohl; M Nimtz; H S Conradt
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

3.  Detailed acceptor specificities of human alpha1,3-fucosyltransferases, Fuc-TVII and Fuc-TVI.

Authors:  K Shinoda; E Tanahashi; K Fukunaga; H Ishida; M Kiso
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

4.  Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly(C) tracts in alpha3-fucosyltransferase genes.

Authors:  B J Appelmelk; S L Martin; M A Monteiro; C A Clayton; A A McColm; P Zheng; T Verboom; J J Maaskant; D H van den Eijnden; C H Hokke; M B Perry; C M Vandenbroucke-Grauls; J G Kusters
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  In vitro alpha1-3 or alpha1-4 fucosylation of type I and II oligosaccharides with secreted forms of recombinant human fucosyltransferases III and VI.

Authors:  M Nimtz; E Grabenhorst; U Gambert; J Costa; V Wray; M Morr; J Thiem; H S Conradt
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

6.  GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation.

Authors:  Kenta Moriwaki; Shinichiro Shinzaki; Eiji Miyoshi
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

Review 7.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

8.  Differential expression of anti-glycan antibodies in schistosome-infected humans, rhesus monkeys and mice.

Authors:  Anthony E Luyai; Jamie Heimburg-Molinaro; Nina Salinger Prasanphanich; Megan L Mickum; Yi Lasanajak; Xuezheng Song; A Kwame Nyame; Patricia Wilkins; Carlos A Rivera-Marrero; David F Smith; Irma Van Die; W Evan Secor; Richard D Cummings
Journal:  Glycobiology       Date:  2014-04-11       Impact factor: 4.313

9.  Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite.

Authors:  Nina Salinger Prasanphanich; Anthony E Luyai; Xuezheng Song; Jamie Heimburg-Molinaro; Msano Mandalasi; Megan Mickum; David F Smith; A Kwame Nyame; Richard D Cummings
Journal:  Glycobiology       Date:  2014-04-11       Impact factor: 4.313

Review 10.  E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy.

Authors:  Mariana Silva; Paula A Videira; Robert Sackstein
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.